Refractory thoracic conidiobolomycosis treated with mepolizumab immunotherapy

J Allergy Clin Immunol Pract. 2021 Jun;9(6):2527-2530.e6. doi: 10.1016/j.jaip.2021.01.044. Epub 2021 Feb 16.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Humans
  • Immunotherapy
  • Zygomycosis*

Substances

  • Antibodies, Monoclonal, Humanized
  • mepolizumab

Supplementary concepts

  • entomophthoromycosis